Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -4.92 is 308% below its 5-year average of -1.21, around the middle of its 5-year range (-9.28–-0.81).
As of the fiscal period ended Tuesday, June 30, 2026. 10.48% above its 12-month average of -5.50.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -4.92.
DEBT TO EQUITY RATIO
-4.92
DEBT TO EQUITY RATIO AVG TTM
-5.50
DEBT TO EQUITY RATIO AVG 3Y
-2.84
DEBT TO EQUITY RATIO AVG 5Y
-1.21
DEBT TO EQUITY RATIO AVG 10Y
-0.91
DEBT TO EQUITY RATIO AVG 15Y
-1.14
DEBT TO EQUITY RATIO AVG 20Y
-1.01
CURRENT VS TTM AVG
+10.48%
CURRENT VS 3Y AVG
-73.39%
CURRENT VS 5Y AVG
-307.74%
CURRENT VS 10Y AVG
-438.29%
CURRENT VS 15Y AVG
-330.82%
CURRENT VS 20Y AVG
-385.35%
SECTOR MEDIAN · HEALTHCARE
0.11
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
-4575.96%
vs the sector median at left
MannKind Corporation
Market Cap
$1.21B
Debt to Equity Ratio
-4.92
TTM Avg
-5.50
3Y Avg
-2.84
5Y Avg
-1.21
Market Cap
$1.21B
Debt to Equity Ratio
0.01
TTM Avg
0.02
3Y Avg
0.04
5Y Avg
0.03
Market Cap
$1.22B
Debt to Equity Ratio
0.37
TTM Avg
0.40
3Y Avg
0.41
5Y Avg
0.36
Market Cap
$1.19B
Debt to Equity Ratio
0.02
TTM Avg
0.02
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$1.16B
Debt to Equity Ratio
0.00
TTM Avg
0.05
3Y Avg
0.03
5Y Avg
0.02
Market Cap
$1.15B
Debt to Equity Ratio
0.15
TTM Avg
1.67
3Y Avg
1.15
5Y Avg
0.83
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MannKind Corporation (MNKD) | $1.21B | -4.92 | -5.50 | -2.84 | -1.21 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.21B | 0.01 | 0.02 | 0.04 | 0.03 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 0.37 | 0.40 | 0.41 | 0.36 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 0.00 | 0.00 | 0.00 | 0.00 |
| Omada Health (OMDA)vs › | $1.22B | 0.00 | 0.23 | 0.24 | 0.24 |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.19B | 0.02 | 0.02 | 0.02 | 0.02 |
| Kardigan, Inc. (KARD)vs › | $1.25B | 0.02 | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.16B | 0.00 | 0.05 | 0.03 | 0.02 |
| Nektar Therapeutics (NKTR)vs › | $1.15B | 0.15 | 1.67 | 1.15 | 0.83 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 0.90 | 0.86 | 0.72 | 0.55 |
Debt/Equity
-4.92
Current Ratio
1.72
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -4.92 |
| 2026-03-31 | -7.38 |
| 2025-12-31 | -9.28 |
| 2025-09-30 | -5.07 |
| 2025-06-30 | -0.85 |
| 2025-03-31 | -0.81 |
| 2024-12-31 | -1.99 |
| 2024-09-30 | -1.14 |
| 2024-06-30 | -1.02 |
| 2024-03-31 | -1.16 |
| 2023-12-31 | -1.11 |
| 2023-09-30 | -1.10 |
| 2023-06-30 | -1.07 |
| 2023-03-31 | -1.09 |
| 2022-12-31 | -1.15 |
| 2022-09-30 | -1.17 |
| 2022-06-30 | -1.13 |
| 2022-03-31 | -1.26 |
| 2021-12-31 | -1.38 |
| 2021-09-30 | -1.52 |
| 2021-06-30 | -1.56 |
| 2021-03-31 | -1.91 |
| 2020-12-31 | -0.68 |
| 2020-09-30 | -0.66 |
| 2020-06-30 | -0.69 |
| 2020-03-31 | -0.61 |
| 2019-12-31 | -0.64 |
| 2019-09-30 | -0.66 |
| 2019-06-30 | -0.53 |
| 2019-03-31 | -0.56 |
| 2018-12-31 | -0.59 |
| 2018-09-30 | -0.51 |
| 2018-06-30 | -0.63 |
| 2018-03-31 | -0.63 |
| 2017-12-31 | -0.73 |
| 2017-09-30 | -0.66 |
| 2017-06-30 | -0.74 |
| 2017-03-31 | -0.75 |
| 2016-12-31 | -0.81 |
| 2016-09-30 | -0.80 |
| 2016-06-30 | -0.61 |
| 2016-03-31 | -0.59 |
| 2015-12-31 | -0.40 |
| 2015-09-30 | -1.56 |
| 2015-06-30 | -2.18 |
| 2015-03-31 | -2.29 |
| 2014-12-31 | -0.67 |
| 2014-09-30 | -5.44 |
| 2014-06-30 | -4.01 |
| 2014-03-31 | 9.93 |
| 2013-12-31 | -4.82 |
| 2013-09-30 | -1.30 |
| 2013-06-30 | -2.18 |
| 2013-03-31 | -2.26 |
| 2012-12-31 | -1.96 |
| 2012-09-30 | -1.57 |
| 2012-06-30 | -1.76 |
| 2012-03-31 | -1.78 |
| 2011-12-31 | -1.56 |
| 2011-09-30 | -1.74 |
| 2011-06-30 | -1.84 |
| 2011-03-31 | -2.13 |
| 2010-12-31 | -2.40 |
| 2010-09-30 | -2.54 |
| 2010-06-30 | -2.58 |
| 2010-03-31 | -3.15 |
| 2009-12-31 | -4.69 |
| 2009-09-30 | -109.20 |
| 2009-06-30 | -12.84 |
| 2009-03-31 | 6.10 |
| 2008-12-31 | 1.64 |
| 2008-09-30 | 0.69 |
| 2008-06-30 | 0.50 |
| 2008-03-31 | 0.38 |
| 2007-12-31 | 0.31 |
| 2007-09-30 | 0.62 |
| 2007-06-30 | 0.45 |
| 2007-03-31 | 0.35 |
| 2006-12-31 | 0.29 |
| 2006-09-30 | 0.81 |
| 2006-06-30 | 0.00 |
| 2006-03-31 | 0.00 |
| 2005-12-31 | 0.00 |
| 2005-09-30 | 0.00 |
| 2005-06-30 | 0.00 |
| 2005-03-31 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-09-30 | 0.00 |
| 2004-06-30 | 0.00 |
| 2004-03-31 | 0.00 |
| 2003-03-31 | 0.00 |
